Published in Curr Opin Biotechnol on December 01, 2004
Self-adjuvanting bacterial vectors expressing pre-erythrocytic antigens induce sterile protection against malaria. Front Immunol (2013) 0.80
Rectal single dose immunization of mice with Escherichia coli O157:H7 bacterial ghosts induces efficient humoral and cellular immune responses and protects against the lethal heterologous challenge. Microb Biotechnol (2011) 0.79
Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers. PLoS One (2015) 0.79
Protective efficacy by various doses of Salmonella ghost vaccine candidate carrying enterotoxigenic Escherichia coli fimbrial antigen against neonatal piglet colibacillosis. Can J Vet Res (2016) 0.75
Effectiveness of F18(+) Fimbrial Antigens Released by a Novel Autolyzed Salmonella Expression System as a Vaccine Candidate against Lethal F18(+) STEC Infection. Front Microbiol (2016) 0.75
Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics. Int J Pharm Investig (2014) 0.75
Bacterial ghosts as adjuvants: mechanisms and potential. Vet Res (2017) 0.75
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 41.47
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 26.95
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet (2012) 11.32
A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry (2007) 7.49
A systematic review of the prevalence of schizophrenia. PLoS Med (2005) 6.99
The global epidemiology and contribution of cannabis use and dependence to the global burden of disease: results from the GBD 2010 study. PLoS One (2013) 2.17
A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr Bull (2003) 1.88
Aurantimonas coralicida gen. nov., sp. nov., the causative agent of white plague type II on Caribbean scleractinian corals. Int J Syst Evol Microbiol (2003) 1.68
Psychotic-like experiences in major depression and anxiety disorders: a population-based survey in young adults. Schizophr Bull (2009) 1.65
Psychopathology during childhood and adolescence predicts delusional-like experiences in adults: a 21-year birth cohort study. Am J Psychiatry (2009) 1.62
Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry (2004) 1.45
A sensitive LC/MS/MS assay of 25OH vitamin D3 and 25OH vitamin D2 in dried blood spots. Clin Chim Acta (2009) 1.39
Introduction of an enhanced recovery protocol for radical cystectomy. BJU Int (2008) 1.35
A novel recombinant multisubunit vaccine against Chlamydia. J Immunol (2004) 1.34
Paternal and maternal age as risk factors for psychosis: findings from Denmark, Sweden and Australia. Schizophr Res (2004) 1.28
Meta-analyses of the incidence and prevalence of schizophrenia: conceptual and methodological issues. Int J Methods Psychiatr Res (2008) 1.28
The antecedents of schizophrenia: a review of birth cohort studies. Schizophr Bull (2008) 1.27
Application of broad-range 16S rRNA PCR amplification and DGGE fingerprinting for detection of tick-infecting bacteria. J Microbiol Methods (2003) 1.21
Psychomotor control in a virtual laparoscopic surgery training environment: gaze control parameters differentiate novices from experts. Surg Endosc (2010) 1.19
Bacterial ghosts as vaccine candidates for veterinary applications. J Control Release (2002) 1.18
Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco. Am J Med Genet A (2008) 1.16
Microarray-based identification of bacteria in clinical samples by solid-phase PCR amplification of 23S ribosomal DNA sequences. J Clin Microbiol (2004) 1.16
Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies. Psychother Psychosom (2014) 1.15
Predicted Relative Metabolomic Turnover (PRMT): determining metabolic turnover from a coastal marine metagenomic dataset. Microb Inform Exp (2011) 1.14
Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics (2007) 1.13
Emended descriptions of the genus Micrococcus, Micrococcus luteus (Cohn 1872) and Micrococcus lylae (Kloos et al. 1974). Int J Syst Evol Microbiol (2002) 1.12
Association between trauma exposure and delusional experiences in a large community-based sample. Br J Psychiatry (2007) 1.11
Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Brain Res Dev Brain Res (2004) 1.05
Communicating about medications during primary care outpatient visits: the role of electronic medical records. Inform Prim Care (2005) 1.05
Psychotic-like experiences in the general community: the correlates of CIDI psychosis screen items in an Australian sample. Psychol Med (2005) 1.05
Monitoring the colonization of monuments by bacteria: cultivation versus molecular methods. Environ Microbiol (2003) 1.04
As the twig is bent, the tree inclines: adult mental health consequences of childhood adversity. Arch Gen Psychiatry (2010) 1.04
Bacterial ghosts as an oral vaccine: a single dose of Escherichia coli O157:H7 bacterial ghosts protects mice against lethal challenge. Infect Immun (2005) 1.02
Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One (2008) 1.02
Phylogenetic 16S rRNA analysis reveals the presence of complex and partly unknown bacterial communities in Tito Bustillo cave, Spain, and on its Palaeolithic paintings. Environ Microbiol (2002) 1.01
Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates. Infect Immun (2003) 1.01
Correlates of delusion-like experiences in a non-psychotic community sample. Aust N Z J Psychiatry (2008) 1.00
The incidence of Streptococcus pneumoniae otitis media is affected by the polymicrobial environment particularly Moraxella catarrhalis in a mouse nasal colonisation model. Microbes Infect (2009) 1.00
Alternate phase variation in expression of two major surface membrane proteins (MBA and UU376) of Ureaplasma parvum serovar 3. FEMS Microbiol Lett (2009) 1.00
The Bacterial Ghost platform system: production and applications. Bioeng Bugs (2011) 1.00
Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery. Expert Rev Vaccines (2003) 0.99
Correlates of victimisation amongst people with psychosis. Soc Psychiatry Psychiatr Epidemiol (2004) 0.99
The prevalence and correlates of hallucinations in Australian adolescents: results from a national survey. Schizophr Res (2008) 0.99
Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis. Vaccine (2003) 0.99
Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine. J Microbiol Immunol Infect (2007) 0.99
Phylogenetic diversity of bacteria associated with Paleolithic paintings and surrounding rock walls in two Spanish caves (Llonín and La Garma). FEMS Microbiol Ecol (2004) 0.99
Bacterial ghosts as adjuvant particles. Expert Rev Vaccines (2007) 0.98
Modelling disease frequency measures in schizophrenia epidemiology. Schizophr Res (2008) 0.97
Substance misuse in patients with schizophrenia: epidemiology and management. Drugs (2002) 0.97
Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits. Vaccine (2003) 0.96
Bacterial ghosts as antigen delivery vehicles. Adv Drug Deliv Rev (2005) 0.96
Identification of a homozygous deletion mutation in C16orf57 in a family with Clericuzio-type poikiloderma with neutropenia. Am J Med Genet A (2010) 0.96
Agrococcus baldri sp. nov., isolated from the air in the 'Virgilkapelle' in Vienna. Int J Syst Evol Microbiol (2002) 0.95
Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors. Expert Rev Vaccines (2004) 0.95
Comparative immunogenicity of the hepatitis B virus core 149 antigen displayed on the inner and outer membrane of bacterial ghosts. Vaccine (2005) 0.95
Should burden of disease estimates include cannabis use as a risk factor for psychosis? PLoS Med (2009) 0.94
Vitamin D in fetal brain development. Semin Cell Dev Biol (2011) 0.93
Bacterial ghosts are an efficient delivery system for DNA vaccines. J Immunol (2004) 0.93
Developing basic hand-eye coordination skills for laparoscopic surgery using gaze training. BJU Int (2010) 0.92
Modifiable risk factors for schizophrenia and autism--shared risk factors impacting on brain development. Neurobiol Dis (2012) 0.91
The association between physical health and delusional-like experiences: a general population study. PLoS One (2011) 0.91
Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol (2004) 0.91
Applications of bacterial ghosts in biomedicine. Adv Exp Med Biol (2009) 0.91
Olanzapine vs risperidone in the management of schizophrenia: a randomized double-blind trial in Australia and New Zealand. Schizophr Res (2003) 0.89
Modelling the incidence and mortality of psychotic disorders: data from the second Australian national survey of psychosis. Aust N Z J Psychiatry (2013) 0.88
Modelling the contribution of family history and variation in single nucleotide polymorphisms to risk of schizophrenia: a Danish national birth cohort-based study. Schizophr Res (2011) 0.87
Anxiety and depressive disorders are associated with delusional-like experiences: a replication study based on a National Survey of Mental Health and Wellbeing. BMJ Open (2012) 0.87
DNA-loaded bacterial ghosts efficiently mediate reporter gene transfer and expression in macrophages. Mol Ther (2005) 0.87
Maintaining and updating semantic context in schizophrenia: an investigation of the effects of multiple remote primes. Psychiatry Res (2004) 0.87
Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechnol (2004) 0.86
The association between trauma and delusional-like experiences. Psychiatry Res (2011) 0.86
Bacillus barbaricus sp. nov., isolated from an experimental wall painting. Int J Syst Evol Microbiol (2003) 0.86
Vitamin E for neuroleptic-induced tardive dyskinesia. Cochrane Database Syst Rev (2011) 0.86
Is it time to trial vitamin D supplements for the prevention of schizophrenia? Acta Psychiatr Scand (2010) 0.86
Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications. Expert Rev Vaccines (2012) 0.86
Altamira cave Paleolithic paintings harbor partly unknown bacterial communities. FEMS Microbiol Lett (2002) 0.85
Investigation of an anaerobic microbial community associated with a corneal ulcer by denaturing gradient gel electrophoresis and 16S rDNA sequence analysis. Diagn Microbiol Infect Dis (2002) 0.85
A study of trait anhedonia in non-clinical Chinese samples: evidence from the Chapman Scales for Physical and Social Anhedonia. PLoS One (2012) 0.85
Bacterial ghosts as novel efficient targeting vehicles for DNA delivery to the human monocyte-derived dendritic cells. J Immunother (2005) 0.85
Immobilization of plasmid DNA in bacterial ghosts. J Control Release (2005) 0.85
Linkage and association on 8p21.2-p21.1 in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2010) 0.85
Bacterial ghosts as novel advanced drug delivery systems: antiproliferative activity of loaded doxorubicin in human Caco-2 cells. J Control Release (2004) 0.84
Olfactory neural cells: an untapped diagnostic and therapeutic resource. The 2000 Ogura Lecture. Laryngoscope (2002) 0.84
Modulation of gene expression by promoter mutants of the lambdacI857/pRM/pR system. J Biotechnol (2004) 0.84
Incidence of schizophrenia does not vary with economic status of the country: evidence from a systematic review. Soc Psychiatry Psychiatr Epidemiol (2006) 0.84
Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts--a delivery system for the nontypeable Haemophilus influenzae antigen Omp26. FEMS Immunol Med Microbiol (2003) 0.84
Mechanisms of bacterial resistance to antibiotics in infections of COPD patients. Curr Drug Targets (2011) 0.84
Risk factors for schizophrenia. Follow-up data from the Northern Finland 1966 Birth Cohort Study. World Psychiatry (2006) 0.84
Sealed bacterial ghosts--novel targeting vehicles for advanced drug delivery of water-soluble substances. J Drug Target (2003) 0.84
Bacterial ghosts (BGs)--advanced antigen and drug delivery system. Vaccine (2010) 0.84
Urban birth and risk of schizophrenia: a worrying example of epidemiology where the data are stronger than the hypotheses. Epidemiol Psichiatr Soc (2007) 0.83
Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery. Expert Opin Drug Deliv (2006) 0.83